NOT-NS-04-016: Revised NINDS Acceptance Policy for Exploratory/Developmental Grant (R21) – Notice of Modification to NINDS R21 Program Guidelines

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Revised NINDS Acceptance Policy for Exploratory/Developmental Grant (R21) Notice of Modification to NINDS R21 Program Guidelines

Notice Number: NOT-NS-04-016

Key Dates
Release Date: October 18, 2004

Issued by
National Institute of Neurological Disorders and Stroke (NINDS), (http://www.ninds.nih.gov)

Purpose

The purpose of this Notice is to revise current National Institute of Neurological Disorders and Stroke (NINDS) policy regarding unsolicited investigator-initiated exploratory/developmental research grant (R21) applications, which states that NINDS will not accept non-exempt human subjects research. Beginning with the February 1, 2005 receipt date, R21 applications with human subjects may be submitted if the following conditions are met:

the proposal does not include any clinical intervention;
the proposed research includes safety monitoring of human subjects that can be performed appropriately within the budgetary and time constraints of the R21 mechanism.

Any R21 application that does not meet the above criteria or does not provide adequate plans for the protection of the safety, privacy and confidentiality of study participants will not be funded. Applicants are encouraged to contact NINDS program staff or visit the NINDS R21 Program website (http://www.ninds.nih.gov/funding/r21guidelines.htm), if they have questions about this R21 policy.

Direct your questions about this Notice to:

NINDS Referral Officer
6001 Executive Boulevard, Room 3208
Bethesda, MD 20892
Phone: (301) 496-9223
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices